The Safety and Efficacy of SeQuent® Please in Real World Chinese Coronary Instent Restenosis Patients

Inclusion Criteria: Criteria related to subjects * At the age of 18-80, Both male and female; * Patients with coronary In sentrestenosis and suitable for the theory of Drug Eluting PTCA Balloon Catheter（SeQuent® Please）, no more than 1 target lesion in each coronary artery * After pre-dilation of target lesion, the residual stenosis is ≥ 30% , patients with type B dissection * Patients must agree to sign the ICF and to undergo the clinical follow-up at 30 days, 6 months, 6 months, 12 months, 24 months, 36months, 48 months and 60 months after operation Criteria related to lesions * The target lesion length and target vessel diameter should be consistent with the instructions of Drug Eluting PTCA Balloon Catheter（SeQuent® Please） Exclusion Criteria: Criteria related to subjects * Women with pregnancy or lactation * Patient with cardiac shock * Patients with Hemorrhagic physique or active gastrointestinal ulcers, with cerebral apoplexy or transient cerebral ischemia within 3 months, who couldn't be tolerated the expected aspirin and/or clopidogrel theory * Patients with severe valvular heart disease * Patients with severe congestive heart failure or NYHA class IV heart failure; * Patients who have received heart transplant; * Patients with life expectancy more than 60 months, or those who is difficulties in clinical follow-up. * Patients who are currently involved in any other clinical trial; * Patients that the investigators think that those are not suitable Criteria related to lesions * Chronic total occlusion * Lesion that cannot be treated with PTCA or other interventional techniques; * The vessel diameter \< 2.25 mm * Left main disease needed to be treated Exclusion criteria related to concomitant medication * Patients who are intolerant to aspirin and/or clopidogrel or have a history of neutrophilopenia or thrombocytopenia, or patients with severe hepatic insufficiency and contraindicated for clopidogrel. * Patients who are known to be intolerant or allergic to heparin, contrast agent, paclitaxel, iopromide, rapamycin, polylactic acid - glycolic acid polymer, stainless steel;